| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/06/2004 | EP1414476A1 Bauhinia extracts |
| 05/06/2004 | EP1414473A1 Oral compositions for the treatment of scalp disorders |
| 05/06/2004 | EP1414470A1 Micronutrient phosphates as dietary and health supplements |
| 05/06/2004 | EP1414469A2 Formulation containing (lyso-) phosphatidylserine for the prevention and treatment of stress states in warm-blooded animals |
| 05/06/2004 | EP1414467A2 Topical treatment for mastalgia |
| 05/06/2004 | EP1414466A1 Combinations for the treatment of inflammatory disorders |
| 05/06/2004 | EP1414465A2 Use of inhibitors of progesterone receptor for treating cancer |
| 05/06/2004 | EP1414464A2 Method for treating glaucoma v |
| 05/06/2004 | EP1414463A1 Asymmetric synthesis of kavalactones |
| 05/06/2004 | EP1414462A2 Treatment of renal fibrosis |
| 05/06/2004 | EP1414460A1 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor |
| 05/06/2004 | EP1414459A1 Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
| 05/06/2004 | EP1414458A1 Oral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 05/06/2004 | EP1414457A1 Chiral dinapsoline |
| 05/06/2004 | EP1414456A1 Phenyl derivatives as factor xa inhibitors |
| 05/06/2004 | EP1414455A1 Isoquinoline inhibitors of p38 |
| 05/06/2004 | EP1414454A1 Paroxetine glycyrrhizinate |
| 05/06/2004 | EP1414453A1 Fexofenadine hydrochloride polymorph |
| 05/06/2004 | EP1414452A1 Novel substituted benzimidazole dosage forms and method of using same |
| 05/06/2004 | EP1414451A1 Opioid agonist formulations with releasable and sequestered antagonist |
| 05/06/2004 | EP1414450A1 (pyridinyl and pyrimidyl)trienoic acid derivatives as retinoid x receptor modulators |
| 05/06/2004 | EP1414448A1 Transdermal therapeutic system (reservoir-tts) for using pramipexole and ropinirole |
| 05/06/2004 | EP1414447A1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 05/06/2004 | EP1414446A1 Pramipexol as an anticonvulsive agent |
| 05/06/2004 | EP1414445A1 Partial agonists at the glycine modulatory site of the nmda receptor for treating cognitive dysfunction |
| 05/06/2004 | EP1414444A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 05/06/2004 | EP1414443A1 BENZIMIDAZO 4,5-f]ISOQUINOLINONE DERIVATIVES |
| 05/06/2004 | EP1414442A1 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders |
| 05/06/2004 | EP1414441A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 05/06/2004 | EP1414440A1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 05/06/2004 | EP1414439A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/06/2004 | EP1414438A1 Antineoplastic combinations |
| 05/06/2004 | EP1414437A2 Agent for protection of retinal neurons |
| 05/06/2004 | EP1414436A1 Radioprotective agents |
| 05/06/2004 | EP1414435A1 Crystalline composition containing escitalopram |
| 05/06/2004 | EP1414434A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 05/06/2004 | EP1414433A1 Improved pharmaceutical composition containing a ppar alpha agent and a process for preparing it |
| 05/06/2004 | EP1414432A2 Methods of use for novel sulfur containing organic nitrate compounds |
| 05/06/2004 | EP1414431A2 Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field |
| 05/06/2004 | EP1414430A2 5-aminolevulinic acid and esters, in combination with another photosensitiser, as photosensitising agents in photochemotherapy, and their uses in treating wounds |
| 05/06/2004 | EP1414429A2 Dermatological preparations containing an nsaid |
| 05/06/2004 | EP1414428A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 05/06/2004 | EP1414427A2 Kavalactone compositions and methods of use |
| 05/06/2004 | EP1414426A1 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases |
| 05/06/2004 | EP1414425A1 Amine compounds and inhibiting neurotransmitter reuptake |
| 05/06/2004 | EP1414424A1 Agent for treating the symptoms of dementia disorders containing an additional local anesthetic agent |
| 05/06/2004 | EP1414423A1 Agent for treating depressive disorders containing a local anesthetic agent |
| 05/06/2004 | EP1414421A1 The treatment of lipodystrophy |
| 05/06/2004 | EP1414420A1 Method for the continuous production and coating of self-adhesive compounds on the basis of sbc that includes at least one pharmaceutically active substance |
| 05/06/2004 | EP1414419A1 Pharmaceutical formulations comprising ketoconazole |
| 05/06/2004 | EP1414418A1 Compositions and methods to prevent abuse of opioids |
| 05/06/2004 | EP1414417A4 Pharmaceutical formulation |
| 05/06/2004 | EP1414417A1 Pharmaceutical formulation |
| 05/06/2004 | EP1414416A2 Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery |
| 05/06/2004 | EP1414413A1 Compositions and methods to prevent abuse of opioids |
| 05/06/2004 | EP1414410A1 Nanoparticulate formulations of fenofibrate |
| 05/06/2004 | EP1414409A1 Stabilized oral suspension formulation |
| 05/06/2004 | EP1414408A1 Composition comprising paroxetine and a pharmaceutically acceptable glycyrrhizinate salt |
| 05/06/2004 | EP1414405A1 Invert emulsion containing dhea |
| 05/06/2004 | EP1414403A1 Composition containing a steroid and a glycol |
| 05/06/2004 | EP1414402A1 Cosmetic or dermatological preparations containing a combination of creatinine and/or creatinine derivatives and creatine and/or the derivatives thereof |
| 05/06/2004 | EP1414401A1 Utilization of creatinine and/or creatinine derivatives in cosmetic and dermatological preparations |
| 05/06/2004 | EP1414390A1 Nanocapsules containing a steroid for cosmetic compositions |
| 05/06/2004 | EP1414386A2 Canine cardiac diet |
| 05/06/2004 | EP1414384A2 Synthesis of epothilones and relates analogs |
| 05/06/2004 | EP1414315A1 Complex antioxidant preparation |
| 05/06/2004 | EP1414314A1 Composition for lowering blood cholesterol |
| 05/06/2004 | EP1414297A2 Sodium dodecyl sulfate compositions for inactivating prions |
| 05/06/2004 | EP1369122A4 Anticancer agent |
| 05/06/2004 | EP1353665A4 Treatment of depression |
| 05/06/2004 | EP1307441B1 1,3-dioxolanes with antitussive activity |
| 05/06/2004 | EP1305307B1 Indole derivatives useful for the treatment of cns disorders |
| 05/06/2004 | EP1280802B1 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation |
| 05/06/2004 | EP1268407B1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/06/2004 | EP1263753B1 Imidazol derivatives as raf kinase inhibitors |
| 05/06/2004 | EP1261613B1 Gastro-specific prodrugs |
| 05/06/2004 | EP1261602B1 Imidazol-2-carboxamide derivatives as raf kinase inhibitors |
| 05/06/2004 | EP1261600B1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 |
| 05/06/2004 | EP1257548B1 Benzofuran carboxamides and their therapeutic use |
| 05/06/2004 | EP1228027B1 3-heteroatom substituted and two carbon homologs of 15-hete and methods of use |
| 05/06/2004 | EP1227714B1 Method for producing metabolites from plants cultivated in soil-less medium |
| 05/06/2004 | EP1226438B1 Composite nanospheres and their conjugates with biomolecules |
| 05/06/2004 | EP1222162B1 Novel ltb4-antagonist, method for the production thereof and its use as a medicament |
| 05/06/2004 | EP1194153B1 Taste masked pharmaceutical liquid formulations |
| 05/06/2004 | EP1181027B1 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 05/06/2004 | EP1165138B1 Programmed controlled ovarian stimulation protocol using oral contraceptives |
| 05/06/2004 | EP1163237B1 Amide derivatives |
| 05/06/2004 | EP1161438B1 6-o-substituted macrolides having antibacterial activity |
| 05/06/2004 | EP1147105B1 Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatement of vascular diseases |
| 05/06/2004 | EP1137409B1 Compositions and methods for amelioration of human female sexual dysfunction |
| 05/06/2004 | EP1134216B1 Anti-drug resistant strain agents and antichlamydia agents |
| 05/06/2004 | EP1123283B1 Thiazole-derivatives |
| 05/06/2004 | EP1117645B1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use |
| 05/06/2004 | EP1105139B1 Ophthalmic solution with tetracycline for topical treatment of dry eye disease |
| 05/06/2004 | EP1098626B1 Method for regulating hair growth |
| 05/06/2004 | EP1060181B1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 05/06/2004 | EP1056443B1 Butorphanol sustained release formulations |
| 05/06/2004 | EP1036072B1 Thrombin receptor antagonists |
| 05/06/2004 | EP1019067B1 Methods of using emu oil and active fractions thereof as an insect repellent |
| 05/06/2004 | EP1009390A4 Prolonged anesthesia in joints and body spaces |